The Ministry of Health, Labor and Welfare (MHLW) appears to be ready to begin post-launch drug price adjustments based on cost-effectiveness assessments (CEAs) for the first time since the system was introduced in April 2019. As price tweaks will be…
HOME > ACADEMIA
ACADEMIA
- With Continuing Shortage of Cefazolin, Shipments of 21 Substitutes Being Adjusted Too
April 8, 2019
- Discuss Biosimilar Pricing Separate from High-Cost Medical Expense Benefits: Prof.
March 20, 2019
- NCNP to Set Up New Council to Accelerate Clinical Development of Neuromuscular Disorder Treatments
March 18, 2019
- Feburic Prevents Cerebral, Cardiorenovascular Events: Japan Multicenter Study
March 13, 2019
- Investigators Calling Off Trials on First Hyperlactacidemia Drug with No Significant Improvement Shown
February 28, 2019
- Keio Researchers Start Studying ReQuip for ALS after iPS Screening
February 25, 2019
- Japan OKs World’s 1st iPS Cell Clinical Research for Spinal Cord Injuries
February 19, 2019
- Revised Hyperuricemia Treatment Guidelines Recommend Uric Acid Production Inhibitors to Prevent Kidney Function Decline
January 21, 2019
- Concomitant Insulin a Must for Suglat Use in Type 1 Diabetes: Specialist
January 18, 2019
- 8-Week Treatment with Maviret a Promising First-Line Option for Hepatitis C: Hepatologist
January 11, 2019
- Tokyo Medical and Dental Univ. to Launch Investigator-Led Trial for JAK Inhibitor for CAEBV
January 10, 2019
- Keio Univ. Board OKs World’s 1st iPS Cell Clinical Research for Spinal Cord Injuries
November 29, 2018
- Health Economist Calls for Robust Appraisal Process in Japan CEA System
November 20, 2018
- World’s 1st, Keio Univ. Plans iPS Cell Clinical Research for Spinal Cord Injuries
November 15, 2018
- Hematology Specialist Advises Caution in Using Hemlibra in Children
October 30, 2018
- Research Group Builds New Pathogenic Variants Database for Japanese Hereditary Breast Cancer
October 16, 2018
- I/O Pioneers Win Nobel Prize in Medicine; Honjo Prods Japan Firms to Make More Academic Investment at Home
October 2, 2018
- New Treatment GL for Statin Intolerance Compiled by Atherosclerosis Society, 3 Other Academic Societies
October 1, 2018
- Opdivo Holds Promise as New Option for Malignant Pleural Mesothelioma: Pulmonary Specialist
September 21, 2018
- Oncologist Hails Tagrisso Approval for 1st-Line Lung Cancer Treatment
September 14, 2018
ページ
Biogen’s controversial Alzheimer’s drug aducanumab was filed for Japanese regulatory approval in December. If approved, it will be the first…
Japan’s key reimbursement policy panel on December 20 approved an outline of its FY2020 drug pricing reform next April, with…
The Ministry of Health, Labor and Welfare (MHLW) on November 27 added to the NHI price list Japan’s first biosimilars of Avastin (bevacizumab), Nesp (darbepoetin alfa), and Forteo (teriparatide). The NHI prices of first biosimilars are set at 70% of…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…
After decades in recruitment, I say from experience that there’s a particular way to attract candidates to a given role. Do it right, and you’ll have talent chasing you. Get it wrong, and you’ll be left listening to the crickets…